Pfizer says tweaked COVID-19 shots boost Omicron protection
Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the Omicron variant is safe and works -- just days before regulators debate whether to offer Americans updated booster shots this fall.
The vaccines currently used in the U.S. still offer strong protection against severe COVID-19 disease and death -- especially if people have gotten a booster dose. But those vaccines target the original coronavirus strain and their effectiveness against any infection dropped markedly when the super-contagious Omicron mutant emerged.
Now with Omicron's even more transmissible relatives spreading widely, the Food and Drug Administration is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another COVID-19 surge expected this fall and winter.
Pfizer and its partner BioNTech studied two different ways of updating their shots -- targeting just Omicron, or a combination booster that adds Omicron protection to the original vaccine. They also tested whether to keep today's standard dosage -- 30 micrograms -- or to double the shots' strength.
In a study of more than 1,200 middle-aged and older adults who'd already had three vaccine doses, Pfizer said both booster approaches spurred a substantial jump in Omicron-fighting antibodies.
"Based on these data, we believe we have two very strong Omicron-adapted candidates," Pfizer CEO Albert Bourla said in a statement.
Pfizer's Omicron-only booster sparked the strongest immune response against that variant.
But many experts say combination shots may be the best approach because they would retain the proven benefits of the original COVID-19 vaccine while adding new protection against Omicron. And Pfizer said a month after people received its combo shot, they had a nine- to 11-fold increase in Omicron-fighting antibodies. That's more than 1.5 times better than another dose of the original vaccine.
And importantly, preliminary lab studies show the tweaked shots also produce antibodies capable of fighting Omicron's genetically distinct relatives named BA.4 and BA.5, although those levels weren't nearly as high.
Moderna recently announced similar results from tests of its combination shot, what scientists call a "bivalent" vaccine.
The studies weren't designed to track how well updated boosters prevented COVID-19 cases. Nor is it clear how long any added protection would last.
But the FDA's scientific advisers will publicly debate the data on Tuesday, as they grapple with whether to recommend a change to the vaccines' recipes -- ahead of similar decisions by other countries.
COVID-19 COVERAGE
CTVNews.ca Top Stories
Economists predict a 'mild recession,' but what would that look like in Canada?
With inflation on the rise and central banks poised to increase rates, CTVNews.ca speaks with experts on whether Canada will experience a recession, and if so, what it would look like.

'We've been abandoned': Man dies in B.C. town waiting for health care near ambulance station
For the second time in less than a month, a resident of Ashcroft, B.C., died while waiting for health care after having a heart attack mere metres from a local ambulance station.
'I have to fight for myself': Quadriplegic man says N.S. government told him to live in a hospital
A diving accident at 14-years-old left Brian Parker paralyzed from the chest down. Now at age 49, he's without the person who was caring for him full-time until just last week, after his 68-year-old mother was diagnosed with breast cancer.
Canadian home sales fall for 5th month in a row, down 29 per cent from last July
Canada's average resale home price fell 4.5% from a year ago in July and was down 5.4% on the month as buyers continued to sit on the sidelines amid rising borrowing costs.
Wet'suwet'en pipeline protest blocks Vancouver traffic
A large rally planned in Vancouver to protest the Coastal GasLink pipeline in northern B.C. blocked traffic Monday morning.
New COVID-19 booster targeting Omicron, original variants approved in U.K.
British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant.
Thousands of Afghans who helped Canada trapped in Afghanistan, struggling to leave
The federal government needs to do more to help thousands of Afghans who assisted Canadian Forces but remain trapped in Afghanistan a year after the Taliban seized Kabul, aid groups and opposition parties say.
Pfizer CEO tests positive for COVID-19, has mild symptoms
The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.
Prince Harry, Meghan to visit U.K., Germany next month
Prince Harry and his wife Meghan, the Duchess of Sussex, will visit the U.K. next month for the first time since they returned for Queen Elizabeth II 's Platinum Jubilee celebrations.